STEMPOINT CAPITAL LP

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1952142 NEW YORK, NY

Position in AMLX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,902,099

-$2,406,522 QoQ

Shares Held

384,304

-42.6% QoQ

Ownership

0.345%

of shares outstanding

% of Portfolio

1.19%

of 13F equity value

Holder Rank

#46

of 207 holders

Holding Since

Dec 2023

5 quarters on record

Voting authority Sole 86% Shared 0% None 14%

Healthcare · as of Jun 30, 2026

STEMPOINT CAPITAL LP holds $44,655,430 across 4 Drug Manufacturers - Specialty & Generic names. AMLX ranks #4 (15.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KNSA	Kiniksa Pharmaceuticals International, plc	209,234	$13,380,514
2	ALKS	Alkermes plc.	248,015	$12,995,986
3	BIOA	BioAge Labs, Inc.	464,171	$11,376,831
4	AMLX	Amylyx Pharmaceuticals, Inc. This page	384,304	$6,902,099

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,902,099	384,304	-42.6%	Shares	Sole	2026-08-14
2026-03-31	$9,308,621	669,685	+18.5%	Shares	Sole	2026-05-15
2025-12-31	$6,826,891	565,140	+104.1%	Shares	Sole	2026-02-17
2025-09-30	$3,762,853	276,884	+232.1%	Shares	Sole	2025-11-14
2023-12-31	$1,227,368	83,381	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.